In association with Fish & Richardson. With US and China being increasingly the main dominant source of investment for life science companies, how should companies balance their engagement? Furthermore, how do the broader US-China relations impact the flow of investment into other markets, such as the UK.
Panel:
Mike Ward, Global Head of Thought Leadership, Clarivate (Moderator)
Chad Shear, Principal, Fish & Richardson
Simon Haworth, CEO, Dynasty Bio
Hayley French, CEO, Apitope
Yuehua Cong, Executive Director, Head of BD&L and Strategic Investment Management, Simcere Pharmaceutical Group
Delegates have the option of attending online or in-person, but not in the traditional hybrid format, as follows:
Copyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.